|
Auto Retractable Safety Syringe wins
2010 Medical Device Excellence Award
Globe Medical Tech – the maker of the
FreeVac safety syringe – has received a
2010 Medical Design Excellence Award
for the FreeVac Vacuum Operated Auto-
Retractable Safety Syringe.
The FreeVac is a new patented safety
syringe that comes with vacuum-operated
automatic retractable technology.
Designed with healthcare providers in
mind, the FreeVac utilises vacuum force
to retract the used needle into the barrel
of the syringe after an injection is administered.
This syringe is intended to
replace conventional syringes and to
reduce the possibility of needle stick
injuries. Accidental needle stick injuries
account for a significant number of
injuries to medical professionals.
The Medical Design Excellence Awards
competition is the only awards programme
that exclusively recognises contributions
and advances in the design of medical
products. Entries are evaluated on the basis
of their design and engineering features,
including innovative use of materials, userrelated
functions that improve healthcare
delivery and change traditional medical
attitudes or practices, features that provide
enhanced benefits to the patient, and the
ability of the product development team to
overcome design and engineering challenges
so that the product meets its clinical
objectives.
“Every engineer told me the same thing
at the beginning of the design work: It is
impossible to create such a strong and fast vacuum force in a device as small as
a 3 cc
syringe,” said Andy Hu, President of Globe
Medical Tech. “However, we were able to
overcome the design challenges after two
years of effort. This is yet another significant
milestone which demonstrates Globe
Medical Tech’s robust design and execution
capabilities. I want express my great
appreciation to our engineering team.”
The FreeVac’s major advantages include:
● Vacuum Force: It uses free air (vacuum
force created when finishing the injection
process and then further pushing
the plunger cover). The vacuum force
retracts the used needle into the barrel.
This process serves to reduce defective
rates and costs.
● Automatic needle retraction:
Retraction requires no significant effort
for users and reduces accidental needlestick
injuries during procedures.
● No recapping: After the needle is
retracted into the barrel, no recap over
an exposed needle is required as is with
the traditional syringe.
● One-handed operation: Keeps hand
away from the needle during the entire
injection process.
● Safety mechanism: Retraction of needle
into the barrel permanently prevents the
syringe from being reused or recycled.
● See brief demo on YouTube:
http://www.youtube.com/globemedtech
● For more information visit:
www.globemedtech.com

Berchtold adds Endolite
to Chromophare line
Berchtold, the specialist for OR equipment, has added the 360° EndoLite
to its award-winning Chromophare LED surgical lighting line. Now, in
addition to class-leading intensity, flexibility and ease of use, LED light
offers a unified downward-facing and upward-facing ambient lighting
system that provides illumination: down at the field for the surgeon; up
and out to the back tables for the rest of the surgical staff.
At the touch of a button, the new 360° EndoLite provides light at the
right time and in all the right places. It is ideal for endoscopic procedures.
● For more information visit:
www.berchtold.biz

The ‘green’ syringe
Cambridge Consultants has launched a novel pre-filled syringe
concept ‘Syreen’. With it innovative ‘green’ syringe design,
Syreen is a safe and easy-to-use drug delivery device for selfadministration
use. It is designed to ease material wastage associated
with traditional syringe development and manufacture.
Syreen syringes are made with COP (cyclic olefin polymer)
plastic. The makeup of the Syreen allows syringes to clip together,
nesting in a pack while the COP design doubles as the outer shell
of the packaging itself. The Syreen therefore eliminates the need
for wasteful fillers such as cardboard and styrofoam, reducing the
packaging weight by 30% and volume by 50% from standard
packaging.
To use Syreen, simply unclip the prefilled syringe and put it
against the desired area on the skin. After delivery, with a simple
snap, the user ejects the needle into the sharps bin, allowing the
user to potentially recycle the plastic capsule. Patient and healthcare
provider safety is also increased due to two further features of
the design. Firstly, the COP plastic syringe features a curved
surface over the needle that, while keeping the syringe from
rolling and reducing needle-stick accidents, also ensures overall
stability and depth control during injection. Secondly, the design
insures that, with separated plunger and stopper, it is impossible
to take in blood or other contaminants, reducing the risk of cross
infection.
Cambridge Consultants is currently seeking to develop the Syreen concept with large pharmaceutical and pharmaceutical
packaging companies.
● For more information visit:
www.cambridgeconsultants.com

A completely new kind of ligation
Conventional electrocoagulation reaches
its limit at vessels with a diameter of more
than approximately 2 mm. In this case,
haemostasis and a permanent seal can
only be achieved with ligation bipolar
vessel sealing: the bunched vessels or
tissue are gripped by a special instrument
and pressed together under a constant,
specified level of pressure. Several automatically
regulated cycles of current (less
than 200 V, but with 4 A of power and an
output of up to 250 W) “weld” the two
opposing vessel walls together. With the
new, quick Ligation ARC 350L V 2.6 this
procedure lasts just 5 seconds on average
and stops automatically when finished.
This completely new method of controlling
the sealing procedure is carried out
with a variable number of pulses with
programmable intensity.
Individual fine adjustment is also
possible, depending on the instrument
and the tissue. Exact preparation of the
vessels is usually not required: entire
bunches of tissue, complete with vessels,
can be gripped and sealed. The process
has the correct effect when the translucent
white coagulation zone can be seen,
within which the tissue can then be
safely cut. In some cases it might be
worthwhile creating two seals a short
distance apart and making the incision
between them. Using this device it is
possible to carry out bipolar sealing in
vessel up to 10 mm in diameter. It is
endorsed for use up to 7 mm.
The tip of the instrument does get hot
and it is therefore important to maintain
a safe distance from sensitive tissue, and
to be careful of causing accidental coagulation
by touching tissue or by setting the
instrument down.
Extensive research has been carried out
to ascertain whether vessels sealed in this
way are securely closed. After the procedure,
the bursting pressure in more than
90% of cases was at more than 400 mm
Hg (up to 900 mm Hg) – generally well
above blood pressure values observed in
clinical practice.
Bipolar vessel sealing has several main
advantages over other procedures such as
ligature, suture and the use of clips: quick
preparation, quick and safe vessel sealing,
no foreign bodies left in the area of the
operation, and low costs. This means that
there is a shorter operating time and less
blood loss, which in turn means better care
for the patient.
The integrated cutting function on the NightKNIFE reduces loss of time caused by
changing instruments. The high degree of
efficiency due to the concept of reusability is
a particularly strong economic incentive for
using the BOWA NightKNIFE, TissueSeal
and LIGATOR ligation instruments. The
fields of application for these sealing instruments
extend from numerous open and
laparoscopic interventions to the specialist
areas of surgery, gynaecology and urology.
● For more information visit:
www.bowa-medical.com

The first step to infection control
in healthcare facilities
Studies have shown that approximately
10% of patients in hospitals in developed
countries contract a hospital-acquired
infection such as C. difficile Colitis,
MRSA, or VRSA. These are just some of
the superbugs giving facilities worldwide
great concern. Attaining and maintaining
a hygienic condition in healthcare facilities
has become a major focus in the battle
against hospital-acquired infections. And
when inhabitants have compromised
immune systems the threat of infection is
further exacerbated.
It is a common misconception that
maintenance departments only require
disinfectants to prevent hospital-acquired
infections. The Centre for Disease
Control, USA states that organic residues
such as blood, pus, urine or faecal material
adversely influence the antimicrobial
activity of disinfectants in many ways.
Disinfectant interference commonly
occurs by a chemical reaction between the
germicide and the organic material
resulting in a complex that is less germicidal
or non-germicidal. Alternatively,
organic material can protect microorganisms
from attack by acting as a physical
barrier. Body fluids once deposited on a
surface also provide ideal breeding grounds
for pathogens. If organic materials are not
adequately removed they can be reinfected
with microbes.
Advait Kotecha, General Manager,
Aseem Trading, distributor for Bio-Pro
Research’s ‘Urine Off’ and ‘Ecokleen’
cleaning products, states “Maximum effectiveness
from disinfection results from first
cleaning and removing organic materials.
The core concept behind Urine Off and
Ecokleen is to eliminate these organic
residues to create a hygienic environment
with no lingering odours. The first step to
hygiene is proper cleaning.”
The Urine Off and Ecokleen products
use specialised enzymes and bacteria to
“eat” body fluids, such as urine, blood and
vomit, including their proteins. The products
eliminate the source of the oldest
stains from practically any surface without
causing damage or discolouration. The
products meet the strict EU standard for
biodegradability and are safe to use
because of their eco-friendly formula.
● For more information visit:
www.bio-proresearch.com/

Date
of upload: 20th June 2010
|